Dr. Gregory Light, Professor in the Department of Psychiatry at UC San Diego and Associate Director of the Clinical Neuroscience Unit, presented at The New York Academy of Sciences recent results from a partnership between Neuroverse and UC San Diego on the use of our brain assessment technology to detect modulations of an important biomarker of neuropsychiatric disorders. His talk was featured in the symposium "Translational Neuroscience in Psychiatry: Light at the End of the Tunnel", stressing the importance of translational solutions for mental pathologies. "For biomarkers to take off, we need to get out of specialty laboratories and into real-world clinical settings" said Dr. Light. "Neuroverse groundbreaking technology is bringing a much needed, personalized and mobile brain-approach to mental health."

Neuroverse continues to partner with leading researchers and clinicians working in a variety of pathologies to develop translational advances for mental health.